ИСТИНА

Charbonnel B.

Соавторы: Bethel M.A., Califf R.M., Diem P., Haffner S.M., McMurray J.J., Мареев В.Ю., Boolell M., Buckley B.M., Chacra A.R., Davies M., Holman R.R., Holzhauer B., Hua T.A. показать полностью..., Masson C., Salinas J.L., Шестакова М.В., Belenkov Y.N., Buse J.B., Buse J.B., C-C C., C-C C., CID-RUZAFA J., Deedwania P., F-T C., F-T C., Fenici P., GARCIA-ALVAREZ L., Godet O., Gomez D., Hammer K.D., Hashigami K., Horton E.S., Jos T., Khunti K., Kosiborod M., Linong J., Macaraeg G., Nicolucci A., Pan C., Watada H., Wojdyla D., Беленков Ю.Н., Сошка В., Томсон С.

5 статей

Количество цитирований статей в журналах по данным Web of Science: 916, Scopus: 981

IstinaResearcherID (IRID): 72245892

Деятельность

• Статьи в журналах

  • 
    • 2018 Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: retrospective data for 10 256 individuals from the United Kingdom and Germany
    • Khunti Kamlesh, Godec Thomas R., Medina Jesús, Garcia-Alvarez Laura, Hiller Josh, Gomes Marilia B., Cid-Ruzafa Javier, Charbonnel Bernard, Fenici Peter, Hammar Niklas, Hashigami Kiyoshi, Kosiborod Mikhail, Nicolucci Antonio, Shestakova Marina V., Linong Ji, Pocock Stuart
    • в журнале Diabetes, Obesity and Metabolism, издательство Blackwell Publishing Inc. (United Kingdom), том 20, № 2, с. 389-399
  • 
    • 2017 Towards an improved global understanding of treatment and outcomes in people with type 2 diabetes: Rationale and methods of the DISCOVER observational study program
    • Linong Ji, Bonnet Fabrice, Charbonnel Bernard, Gomes Marilia B., Kosiborod Mikhail, Khunti Kamlesh, Nicolucci Antonio, Pocock Stuart, Rathmann Wolfgang, Shestakova Marina V., Shimomura Iichiro, Watada Hirotaka, Fenici Peter, Hammar Niklas, Hashigami Kiyoshi, Macaraeg Greg, Surmont Filip, Medina Jesús
    • в журнале Journal of Diabetes and its Complications, издательство Elsevier BV (Netherlands), том 31, № 7, с. 1188-1196 DOI
  • 
    • 2013 Role of diuretics, blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study
    • Shen L., Shah B.R., Reyes E.M., Thomas L., Wojdyla D., Diem P., Leiter L.A., Charbonnel B., Mareev V., Horton E.S., Haffner S.M., Soska V., Holman R., Bethel M.A., Schaper F., Sun J.L., McMurray J.J., Califf R.M., Krum H.
    • в журнале BMJ, том 347, № dec09 7, с. 6745
  • 
    • 2010 EFFECT OF NATEGLINIDE ON THE INCIDENCE OF DIABETES AND CARDIOVASCULAR EVENTS
    • Holman R.R., Bethel M.A., McMurray J.J., Haffner S.M., Davies M.J., Califf R.M., Buse J.B., Holzhauer B., Boolell M., Masson C., Diem P., Hua T.A., Belenkov Y., Mareev V., Buckley B.M., Chacra A.R., F-T Chiang, Charbonnel B., C-C Chow, Pan C.
    • в журнале New England Journal of Medicine, издательство Massachusetts Medical Society (United States), том 362, № 16, с. 1463-1476
  • 
    • 2010 EFFECT OF VALSARTAN ON THE INCIDENCE OF DIABETES AND CARDIOVASCULAR EVENTS
    • Califf R.M., McMurray J.J., Holman R.R., Bethel M.A., Haffner S.M., Holzhauer B., Boolell M., Masson C., Hua T.A., Belenkov Y., Mareev V., Buse J.B., Buckley B.M., Chacra A.R., F-T Chiang, Charbonnel B., C-C Chow, Davies M.J., Deedwania P., Diem P.
    • в журнале New England Journal of Medicine, издательство Massachusetts Medical Society (United States), том 362, № 16, с. 1477-1490